Cases That Test Your Skills

From sweet to belligerent in the blink of an eye

Author and Disclosure Information

 

References

The authors’ observations

Many factors can contribute to behavioral or cognitive changes in geriatric patients. Often, a major change noted in an older patient can be attributed to new-onset dementia, dementia with behavioral disturbances, delirium, depression, or acute psychosis. These potential causes should be considered and ruled out in a step-by-step progression. Because patients are unreliable historians during acute distress, a complete history from family or caregivers and exhaustive workup is paramount.

TREATMENT Medication adjustments

In an attempt to resolve Ms. P’s disruptive behaviors, her risperidone dosage is changed to 0.5 mg twice daily. Ms. P is encouraged to use the provided oxygen to raise her saturation level.

On hospital Day 3, a loose stool prompts a Clostridium difficile test as a possible source of delirium; however, the results are negative.

On hospital Day 4, Ms. P is confused and irritable overnight, yelling profanities at staff, refusing care, inappropriately disrobing, and having difficulty falling asleep and staying asleep. Risperidone is discontinued because it appears to have had little or no effect on Ms. P’s disruptive behaviors. Olanzapine, 10 mg/d, is initiated with mirtazapine, 7.5 mg/d, to help with mood, appetite, and sleep. Fluoxetine is also discontinued because of a possible interaction with clopidogrel.

On hospital Days 6 to 8, Ms. P remains upset and unable to follow instructions. Melatonin is initiated to improve her sleep cycle. On Day 9, she continues to decline and is cursing at hospital staff; haloperidol is initiated at 5 mg every morning, 10 mg at bedtime, and 5 mg IM as needed for agitation. Her sleep improves with melatonin and mirtazapine. IV hydration also is initiated. Ms. P has a slight improvement in medication compliance. On Day 11, haloperidol is increased to 5 mg in the morning, 5 mg in the afternoon, and 10 mg at bedtime. On Day 12, haloperidol is changed to 7.5 mg twice daily; a slight improvement in Ms. P’s behavior is noted.

Continue to: On hospital Day 13...

Pages

Recommended Reading

FDA issues warnings to companies selling illegal Alzheimer’s treatments
MDedge Psychiatry
Boosting Alzheimer’s trial participation via Medicare Advantage ‘memory fitness programs’
MDedge Psychiatry
Biogen, Eisai discontinue aducanumab Alzheimer’s trials
MDedge Psychiatry
New sleep apnea guidelines offer evidence-based recommendations
MDedge Psychiatry
Medical cannabis relieved pain, decreased opioid use in elderly
MDedge Psychiatry
AD biomarker not tied to increased interest in physician-assisted death
MDedge Psychiatry
Experts propose new definition and recommendations for Alzheimer’s-like disorder
MDedge Psychiatry
Lonely elderly patients suffer worse health outcomes
MDedge Psychiatry
Report on newly recognized cause of dementia should be read widely
MDedge Psychiatry
Coding variants in apolipoprotein B may be associated with early-onset Alzheimer’s disease
MDedge Psychiatry